Expression and function of histone deacetylase 10 (HDAC10) in B cell malignancies

Methods in Molecular Biology

Volumn 1436, Issue , 2016, Pages 129-145

  Powers, John ^a   Lienlaf, Maritza ^a   Perez Villarroel, Patricio ^a   Deng, Susan ^a   Knox, Tessa ^a   Villagra, Alejandro ^a   Sahakian, Eva ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Adenoviral overexpression; Genotyping; High throughput flow screening; Histone deacetylase 10; PCR; qRT PCR; Western blotting

Indexed keywords

HISTONE DEACETYLASE 10; HDAC10 PROTEIN, HUMAN; HISTONE DEACETYLASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; CANCER PROGNOSIS; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; MANTLE CELL LYMPHOMA; MANTLE CELL LYMPHOMA CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; WESTERN BLOTTING; ANIMAL; CELL PROLIFERATION; CELL SURVIVAL; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; HIGH THROUGHPUT SCREENING; KNOCKOUT MOUSE; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE;

ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; CELL SURVIVAL; DOWN-REGULATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HIGH-THROUGHPUT SCREENING ASSAYS; HISTONE DEACETYLASES; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, MANTLE-CELL; MICE; MICE, KNOCKOUT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 85007499796     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-3667-0_10     Document Type: Chapter

References (14)

1. Villagra A, Sotomayor EM, Seto E (2010) Histone deacetylases and the immunological network: implications in cancer and inflammation. Oncogene 29(2):157–173
2. Sahakian EW, Karuune; Villagra, Alejandro; and Sotomayor, Eduardo (2013) Epigenetic approaches: emerging role of histone deacetylase inhibitors in cancer immunotherapy. Cancer immunotherapy (2 edn). Academic Press (Elsevier)
3. de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB (2003) Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 370(Pt 3):737–749
4. Lee JH, Jeong EG, Choi MC et al (2010) Inhibition of histone deacetylase 10 induces thioredoxin-interacting protein and causes accumulation of reactive oxygen species in SNU-620 human gastric cancer cells. Mol Cells 30(2):107–112
5. Fischer DD, Cai R, Bhatia U et al (2002) Isolation and characterization of a novel class II histone deacetylase, HDAC10. J Biol Chem 277(8):6656–6666
6. Guardiola AR, Yao TP (2002) Molecular cloning and characterization of a novel histone deacetylase HDAC10. J Biol Chem 277(5): 3350–3356
7. Kao HY, Lee CH, Komarov A, Han CC, Evans RM (2002) Isolation and characterization of mammalian HDAC10, a novel histone deacetylase. J Biol Chem 277(1):187–193
8. Song C, Zhu S, Wu C, Kang J (2013) Histone deacetylase (HDAC) 10 suppresses cervical cancer metastasis through inhibition of matrix metalloproteinase (MMP) 2 and 9 expression. J Biol Chem 288(39):28021–28033
9. Osada H, Tatematsu Y, Saito H, Yatabe Y, Mitsudomi T, Takahashi T (2004) Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients. Int J Cancer 112(1):26–32
10. Jin Z, Jiang W, Jiao F et al (2014) Decreased expression of histone deacetylase 10 predicts poor prognosis of gastric cancer patients. Int J Clin Exp Pathol 7(9):5872–5879
11. Sahakian E, Shah BD, Powers J et al (2011) The opposing role of Histone Deacetylase 10 (HDAC10) and HDAC11 in proliferation/ survival of Mantle Cell Lymphoma (MCL) and Chronic Lymphocytic Leukemia (CLL). Blood 118(21):598
12. Carninci P, Kasukawa T, Katayama S et al (2005) The transcriptional landscape of the mammalian genome. Science 309(5740): 1559–1563
13. Villagra A, Cheng F, Wang HW et al (2009) The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance. Nat Immunol 10(1):92–100
14. Cheng F, Lienlaf M, Wang HW et al (2014) A novel role for histone deacetylase 6 in the regulation of the tolerogenic STAT3/IL-10 pathway in APCs. J Immunol 193(6): 2850–2862